New RSV prevention program shows promise in reducing child hospitalizations
NCT ID NCT07164430
Summary
This study looked at how new RSV prevention medicines given to infants and pregnant mothers affected hospital visits for RSV in children under 2 years old. Researchers used existing health records from 2022-2025 to compare hospitalization rates before and after the prevention program started. The goal was to see if these new prevention options actually reduced serious RSV illness in young children.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS HOSPITALIZATIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Canberra Hospital
Garran, Australian Capital Territory, 2605, Australia
Conditions
Explore the condition pages connected to this study.